Reverse aqueous emulsions and microemulsions in HFA227 propellant stabilized by non-ionic ethoxylated amphiphiles

International Journal of Pharmaceutics

Volumn 369, Issue 1-2, 2009, Pages 176-184

  Chokshi, Udayan ^c   Selvam, Parthiban ^c   Porcar, Lionel ^a,b   da Rocha, Sandro R P ^c  

^a UNIVERSITY OF MARYLAND   (United States)

^b NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

^c Wayne State University   (United States)

Author keywords

Emulsions; HFAs; Inhalation; Microemulsions; Novel Formulations; pMDI; SANS

Indexed keywords

ALCOHOL; AMPHOPHILE; APAFLURANE; ETHYLENE OXIDE; PROPYLENE OXIDE; SURFACTANT; WATER;

ARTICLE; CHEMICAL STRUCTURE; DISPERSION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; FOOD AND DRUG ADMINISTRATION; INHALER; MICROEMULSION; NEUTRON SCATTERING; PRESSURE MEASUREMENT; PRIORITY JOURNAL; ULTRAVIOLET SPECTROSCOPY;

ADMINISTRATION, INHALATION; AEROSOL PROPELLANTS; CHEMISTRY, PHARMACEUTICAL; DRUG STABILITY; EMULSIONS; ETHANOL; HYDROCARBONS, FLUORINATED; METERED DOSE INHALERS; POLYETHYLENES; POLYPROPYLENES; SCATTERING, SMALL ANGLE; SOLVENTS; SPECTROPHOTOMETRY, ULTRAVIOLET; SURFACE TENSION; SURFACE-ACTIVE AGENTS; WATER;

EID: 60849136012     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.10.025     Document Type: Article

References (70)

1. Alexander D.J., and Libretto S.E. An overview of the toxicology of HFA-134a (1,1,1,2-tetrafluoroethane). Human and Experimental Toxicology 14 (1995) 715-720
2. Alexandridis P., and Andersson K. Reverse micelle formation and water solubilization by polyoxyalkylene block copolymers in organic solvent. Journal of Physical Chemistry B 101 41 (1997) 8103-8111
3. Aveyard R., Binks B.P., Clark S., and Fletcher P.D.I. Effects of temperature on the partitioning and adsorption of dodecyl pentaethylene glycol ether in heptane-water mixtures. Journal of the Chemical Society, Faraday Transactions 86 18 (1990) 3111-3115
4. Aveyard R., Binks B.P., and Fletcher P.D.I. Interfacial tensions and aggregate structure in pentaethylene glycol monododecyl ether/oil/water microemulsion systems. Langmuir 5 (1989) 1210-1217
5. Aveyard R., Binks B.P., Lawless T.A., and Mead J. Interfacial tension minima in oil + water + surfactant systems. Effects of salt and temperature in systems containing nonionic surfactants. Journal of the Chemical Society 81 9 (1985) 2155-2168
6. Blondino F.E. Novel Solution Aerosols for Inhalation (1995), Department of Pharmacy and Pharmaceutics, Virginia Commonwealth University, Richmond, Virginia pp. 340
7. Blondino F.E., and Byron P.R. Surfactant dissolution and water solubilization in chlorine-free liquified gas propellants. Drug Development and Industrial Pharmacy 24 10 (1998) 935-945
8. Bowman P.A., and Greenleaf D. Non-CFC metered dose inhalers: the patent landscape. International Journal of Pharmaceutics 186 1 (1999) 91-94
9. Brambilla G., Ganderton D., Garzia R., Lewis D., Meakin B., and Ventura P. Modulation of aerosol clouds produced by pressurised inhalation aerosols. International Journal of Pharmaceutics 186 (1999) 53-61
10. Butz N., Porte C., Courrier H., Krafft M.P., and Vandamme T.F. Reverse water-in-fluorocarbon emulsions for use in pressurized metered-dose inhalers containing hydrofluoroalkane propellants. International Journal of Pharmaceutics 238 1-2 (2002) 257-269
11. Byron P.R., and Patton J.S. Drug delivery via respiratory track. Journal of Aerosol Medicine 7 1 (1994) 49-75
12. Chinet T. Changes in metered dose inhaler propellants. Revue des Maladies Respiratoires 17 1 (2000) 15-20
13. Courrier H.M., Butz N., and Vandamme T.F. Pulmonary drug delivery system: recent developments and prospects. Critical Reviews in Therapeutic Drug Carrier Systems 19 4-5 (2002) 425-498
14. da Rocha S.R.P., Harrison K.L., and Johnston K.P. Effect of surfactants on the interfacial tension and emulsion formation between water and carbon dioxide. Langmuir 15 2 (1999) 419-428
15. 2-water interface. Langmuir 16 8 (2000) 3690-3695
16. Dellamary L.A., Tarara T.E., Smith D.J., and Woelk C.H. Hollow porous particles in metered dose inhalers. Pharmaceutical Research 17 2 (2000) 168-174
17. 2 interface. Industrial and Engineering Chemistry Research 44 5 (2005) 1370-1380
18. DuBoisson R. Surface Tension of HPFP (2005), Synquest Labs, Alachua, FL
19. Edwards D.A., Hanes J., and Caponetti G. Large porous particles for pulmonary drug delivery. Science 276 5320 (1997) 1868-1871
20. Emmen H.H., Hoogendijk E.M.G., Klopping-Ketelaars W.A.A., Muijser H., Duistermaat E., Ravensberg J.C., Alexander D.J., Borkhataria D., Rusch G.M., and Schmit B. Human safety and pharmacokinetics of the CFC alternative propellants HFC 134a (1,1,1,2-tetrafluoroethane) and HFC 227 (1,1,1,2,3,3,3-heptafluoropropane) following whole-body exposure. Regulatory Toxicology and Pharmacology 32 (2000) 22-35
21. Graepel P., and Alexander D.J. CFC replacements: safety testing, approval for use in metered dose inhalers. Journal of Aerosol Medicine 4 3 (1991) 193-200
22. Johnston K.P., Harrison K.L., Clarke M.J., Howdle S.M., Heitz M.P., Bright F.V., Carlier C., and Randolph T.W. Water-in-carbon dioxide microemulsions: a new environment for hydrophiles including proteins. Science 271 (1996) 674
23. Kline S.R. Reduction and analysis of SANS and USANS data using Igor Pro. Journal of Applied Crystallography 39 (2006) 895-900
24. Krafft M.P. Fluorocarbons and fluorinated amphiphiles in drug delivery and biomedical research. Advanced Drug Delivery Reviews 47 (2001) 209-228
25. Krafft M.P., and Riess J.G. Highly fluorinated amphiphiles and colloidal systems, and their applications in the biomedical field. A contribution. Biochimie 80 5-6 (1998) 489-514
26. KSV, 2001. CAM 200-Optical Contact Angle Meter., p Product manual.
27. Laube Beth L. The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination. Respiratory Care 50 9 (2005) 1161-1176
28. Lawrence M.J., and Rees G.D. Microemulsion-based media as novel drug delivery systems. Advanced Drug Delivery Reviews 45 1 (2000) 89-121
29. Lay M.B., Drummond C.J., Thistlethwaite P.J., and Grieser F. ET(30) as a probe for the interfacial microenvironment of water-in-oil microemulsions. Journal of Colloid and Interface Science 128 2 (1989) 602-604
30. Li J.-R., Lee Y.-M., and Yu T. Solubilization of hydrophilic compounds in 1,1,1,2-tetrafluoroethane with a cationic surfactant. Analytical Chemistry 72 (2000) 1348-1351
31. 2 microemulsions with fluorinated co-surfactant by using UV-vis spectroscopy. Journal of Supercritical Fluids 32 1-3 (2004) 97-103
32. McDonald K.J., and Martin G.P. Transition to CFC-free metered dose inhalers-into the new millennium. International Journal of Pharmaceutics 201 1 (2000) 89-107
33. Meakin, B.J., Lewis, D.A., Berrill, S.A., Davies, R.J., 2003. Solubilization of drugs in HFA propellant by means of emulsions, Eur. Pat. Appl., pp. 14 (Chiesi Farmaceutici S.p.A., Italy).
34. Modi P. Pulmonary Drug Delivery (2000), Generex Pharmaceuticals Inc., Canada
35. Owens D.R., Zinman B., and Bolli G. Alternative routes of insulin delivery. Diabetic Medicine 20 11 (2003) 886-898
36. Patel N., Marlow M., and Lawrence M.J. Fluorinated ionic surfactant microemulsions in hydrofluorocarbon 134a (HFC134a). Journal of Colloid and Interface Science 258 2 (2003) 354-362
37. Patel N., Marlow M., and Lawrence M.J. Formation of fluorinated nonionic surfactant microemulsions in hydrofluorocarbon 134a (HFC134a). Journal of Colloid and Interface Science 258 2 (2003) 345-353
38. Patton J.S., and Byron P.R. Inhaling medicines: delivering drugs to the body through the lungs. Nature Reviews Drug discovery 6 (2007) 67-74
39. Patton J.S., Fishburn C.S., and Weers J.G. The lungs as a portal of entry for systemic drug delivery. Proceedings of the American Thoracic Society 1 (2004) 338-344
40. Peguin R.P.S., and da Rocha S.R.P. Solvent-solute interactions in hydrofluoroalkane propellants. Journal of Physical Chemistry B 112 (2008) 8084-8094
41. Peguin R.P.S., Selvam P., and da Rocha S.R.P. Microscopic and thermodynamic properties of the HFA134a-water interface: atomistic computer simulations and tensiometry under pressure. Langmuir 22 21 (2006) 8826-8830
42. Peguin R.P.S., Wu L., and da Rocha S.R.P. The Ester Group: how hydrofluoroalkanephilic is it?. Langmuir 23 16 (2007) 8291-8294
43. Psathas P., da Rocha S.R.P., Ted Lee C.J., Johnston K.P., Lim K.T., and Webber S. Water-in-carbon dioxide emulsions with poly(dimethylsiloxane)-based block copolymer ionomers. Langmuir 39 (2000) 2655-2664
44. Rau J.L. The inhalation of drugs: advantages and problems. Respiratory Care 50 3 (2005) 365-382
45. Ridder K.B., Davies-Cutting C.J., and Kellaway I.W. Surfactant solubility and aggregate orientation in hydrofluoroalkanes. International Journal of Pharmaceutics 295 1-2 (2005) 57-65
46. Rogueda P.G.A. HPFP, a model propellant for pMDIs. Drug Development and Industrial Pharmacy 29 1 (2003) 39-49
47. Rogueda P.G.A. Novel hydrofluoroalkane suspension formulations for respiratory drug delivery. Expert Opinion on Drug Delivery 2 4 (2005) 625-638
48. Sadtler V.M., Krafft M.P., and Riess J.G. Reverse water-in-fluorocarbon emulsions as a drug delivery system: an in vitro study. Colloids and Surfaces A: Physicochemical and Engineering Aspects 147 (1999) 309-315
49. 2 microemulsion. Langmuir 20 7 (2004) 2560-2566
50. Selvam P., Chokshi U., Gouch A., Wu L., Porcar L., and da Rocha S.R.P. Ethoxylated copolymer surfactants for the HFA134a-water interface: interfacial activity, aggregation behavior and biomolecule encapsulation. Soft Matter 4 (2008) 357-366
51. Selvam P., Peguin R.P.S., Chokshi U., and da Rocha S.R.P. Surfactant design for the 1,1,1,2-tetrafluoroethane-water interface: ab initio calculations and in situ high-pressure tensiometry. Langmuir 22 21 (2006) 8675-8683
52. Solvay, 2005. Solvay Fluor und Derivate GmbH & Co. KG, Hamburg.
53. Sommerville M., and Hickey A.J. Microemulsion alternate propellant systems for aerosol drug delivery. Respiratory Drug Delivery VI: Biological, Pharmaceutical, Clinical and Regulatory Issues Relating to Optimized Drug Delivery by Aerosol, the International Symposium. Hilton Head, S.C. (1998) 421-424
54. Sommerville M.L., Cain J.B., Johnson Jr. C.S., and Hickey A.J. Lecithin inverse microemulsions for the pulmonary delivery of polar compounds utilizing dimethyl ether and propane as propellants. Pharmaceutical Development and Technology 5 2 (2000) 219-230
55. Sommerville M.L., Johnson Jr. C.S., Cain J.B., Rypacek F., and Hickey A.J. Lecithin microemulsions in dimethyl ether and propane for the generation of pharmaceutical aerosols containing polar solutes. Pharmaceutical Development and Technology 7 3 (2002) 273-288
56. Steckel H., and Muller B.W. Metered-dose inhaler formulation of fluticasone 17-propionate micronized with supercritical carbon dioxide using the alternative propellant HFA-227. International Journal of Pharmaceutics 173 1-2 (1998) 25-33
57. Stefely J.S. Novel excipients for inhalation drug delivery: expanding the capability of the MDI. Drug Delivery Technology 2 6 (2002) 64-69 62
58. Stefely J.S., Duan D.C., and Myrdal P.B. Design and utility of a novel class of biocompatible excipients for HFA-based MDIs. Respiratory Drug Delivery VII (2000) 83-90
59. Steytler D.C., Thorpe M., Eastoe J., Dupont A., and Heenan R.K. Microemulsion formation in 1,1,1,2-tetrafluoroethane (R134a). Langmuir 19 21 (2003) 8715-8720
60. Svensson B., Olsson U., Alexandridis P., and Mortensen K. A SANS investigation of reverse (water-in-oil) micelles of amphiphilic block copolymers. Macromolecules 32 (1999) 6725-6733
61. Tansey I. The technical transition to CFC-free inhalers. British Journal of Clinical Practice 89 (1997) 22-27
62. Tarara T.E., Hartman M.S., Gill H., Kennedy A.A., and Weers J.G. Characterization of suspension-based metered dose inhaler formulations composed of spray-dried budesonide microcrystals dispersed in HFA-134a. Pharmaceutical Research 21 9 (2004) 1607-1614
63. Vervaet C., and Byron P.R. Drug-surfactant-propellant interactions in HFA-formulations. International Journal of Pharmaceutics 186 1 (1999) 13-30
64. Wang Y.-C.J., and Kowal R.R. Review of excipients and pH's for parenteral products used in the United States. Journal of the Parenteral Drug Association 34 6 (1980) 452-462
65. Williams III R.O., and Liu J. Influence of formulation additives on the vapor pressure of hydrofluoroalkane propellants. International Journal of Pharmaceutics 166 (1998) 99-103
66. Wu L., Al-haydari M., and da Rocha S.R.P. Novel propellant-driven inhalation formulations: engineering polar drug particles with surface-trapped hydrofluoroalkanephiles. European Journal of Pharmaceutical Sciences 33 2 (2008) 146-158
67. Wu L., Bharatwaj B., Panyam J., and da Rocha S.R.P. Core-shell particles for the dispersion of small polar drugs and biomolecules in hydrofluoroalkane propellants. Pharmaceutical Research 25 2 (2007) 289-301
68. Wu L., and da Rocha S.R.P. Biocompatible and biodegradable copolymer stabilizers for hydrofluoroalkane dispersions: a colloidal probe microscopy investigation. Langmuir 23 24 (2007) 12104-12110
69. Wu L., Peguin R.P.S., and da Rocha S.P.R. Understanding solvation in hydrofluoroalkanes: ab initio calculations and chemical force microscopy. Journal of Physical Chemistry B 111 28 (2007) 8096-8104
70. Wu L., Peguin R.P.S., Selvam P., Chokshi U., and da Rocha S.P.R. Molecular scale behavior in alternative propellant-based inhaler formulations. In: Hickey A.J. (Ed). Inhalation Aerosols-Physical and Biological Basis for Therapy (2007), Informa Healthcare USA, New York 373-397